Milestones in tumor vascularization and its therapeutic targeting
M De Palma, D Hanahan - Nature cancer, 2024 - nature.com
Research into the mechanisms and manifestations of solid tumor vascularization was
launched more than 50 years ago with the proposition and experimental demonstrations that …
launched more than 50 years ago with the proposition and experimental demonstrations that …
Targeting the tumour vasculature: from vessel destruction to promotion
S Guelfi, K Hodivala-Dilke, G Bergers - Nature Reviews Cancer, 2024 - nature.com
As angiogenesis was recognized as a core hallmark of cancer growth and survival, several
strategies have been implemented to target the tumour vasculature. Yet to date, attempts …
strategies have been implemented to target the tumour vasculature. Yet to date, attempts …
Transforming “cold” tumors into “hot” ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy
Y Yi, M Yu, C Feng, H Hao, W Zeng, C Lin, H Chen… - Matter, 2022 - cell.com
It is highly desirable to turn" cold" tumors into" hot" ones to improve the efficacy of antitumor
immunotherapy. Herein, we develop the peptide-based small interfering RNA (siRNA) …
immunotherapy. Herein, we develop the peptide-based small interfering RNA (siRNA) …
[HTML][HTML] Targeting breast cancer stem cells
The potential roles of breast cancer stem cells (BCSCs) in tumor initiation and recurrence
have been recognized for many decades. Due to their strong capacity for self-renewal and …
have been recognized for many decades. Due to their strong capacity for self-renewal and …
High endothelial venules (HEVs) in immunity, inflammation and cancer
L Blanchard, JP Girard - Angiogenesis, 2021 - Springer
High endothelial venules (HEVs) are specialized blood vessels mediating lymphocyte
trafficking to lymph nodes (LNs) and other secondary lymphoid organs. By supporting high …
trafficking to lymph nodes (LNs) and other secondary lymphoid organs. By supporting high …
High endothelial venules in cancer: regulation, function, and therapeutic implication
G Vella, Y Hua, G Bergers - Cancer Cell, 2023 - cell.com
The lack of sufficient intratumoral CD8+ T lymphocytes is a significant obstacle to effective
immunotherapy in cancer. High endothelial venules (HEVs) are organ-specific and …
immunotherapy in cancer. High endothelial venules (HEVs) are organ-specific and …
High endothelial venules: A vascular perspective on tertiary lymphoid structures in cancer
G Vella, S Guelfi, G Bergers - Frontiers in immunology, 2021 - frontiersin.org
High endothelial venules (HEVs) are specialized postcapillary venules composed of
cuboidal blood endothelial cells that express high levels of sulfated sialomucins to bind L …
cuboidal blood endothelial cells that express high levels of sulfated sialomucins to bind L …
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
L Zhang, J Xu, S Zhou, F Yao, R Zhang, W You… - Journal of …, 2024 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) is among the most prevalent and
lethal cancers worldwide. The tumor microenvironment (TME) contributes to the poor …
lethal cancers worldwide. The tumor microenvironment (TME) contributes to the poor …
Bioinspired Lipoproteins of Furoxans–Oxaliplatin Remodel Physical Barriers in Tumor to Potentiate T‐Cell Infiltration
Y Wang, H Xie, Y Wu, S Xu, Y Li, J Li, X Xu… - Advanced …, 2022 - Wiley Online Library
The infiltration of cytotoxic T lymphocytes (CTLs) in tumors is critically challenged by the
intricate intratumor physical barriers, which is emerging as an important issue of anticancer …
intricate intratumor physical barriers, which is emerging as an important issue of anticancer …
Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
M Subramanian, AU Kabir, D Barisas, K Krchma… - Cell Reports …, 2023 - cell.com
Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment. However,
only a fraction of patients respond to ICB therapy. Accurate prediction of patients to likely …
only a fraction of patients respond to ICB therapy. Accurate prediction of patients to likely …